Intellia Therapeutics (NTLA) EBT Margin Growth (5y) (2020 - 2026)
Intellia Therapeutics (NTLA) EBT Margin Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Intellia Therapeutics | 1.32 Bn | 1.32 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 585,196.00 |
| Dec 31, 2025 | 237,480.00 |
| Sep 30, 2025 | -130,644.00 |
| Jun 30, 2025 | -32,947.00 |
| Mar 31, 2025 | -124,725.00 |
| Dec 31, 2024 | -70,852.00 |
| Sep 30, 2024 | -114,291.00 |
| Jun 30, 2024 | -168,173.00 |
| Mar 31, 2024 | -5,696.00 |
| Dec 31, 2023 | 876,374.00 |
| Sep 30, 2023 | -23,739.00 |
| Jun 30, 2023 | -30,597.00 |
| Mar 31, 2023 | -50,867.00 |
| Dec 31, 2022 | 9,005.00 |
| Sep 30, 2022 | -57,561.00 |
| Jun 30, 2022 | -72,436.00 |
| Mar 31, 2022 | -260,618.00 |
| Dec 31, 2021 | -45,050.00 |
| Sep 30, 2021 | -919,629.00 |
| Jun 30, 2021 | -1.58 Mn |